Just another day: Part II

Originally written October 16, 2006 (Updated edits in bold red)

On the heels of discussing my cynicism about pharmaceutics and pharmaceutical companies (namely, psychiatric-related), I have a few questions regarding the approach of psychiatric evalutations:

1. Why aren’t people tested for biochemical imbalances?
2. Is there a way to determine from blood work or an MRI what kind of mental illness a person is suffering from (in conjunction with the patient’s psychiatric assessment)?
3. How do doctors know the appropriate dosage for a patient? Does s/he start a patient off on what is considered “normal” for an average person and then increase or reduce the dosage based on reactions and side effects?
4. How does a doctor know when to increase a dosage? (Figuring out when to reduce a dosage SHOULD be much easier.)

Psychiatry is an inexact science. For the most part, I think much of it — regarding medication, Freud, and now, the pharmaceutical industry — is a crock.

Continue reading “Just another day: Part II”

Pharmaceutical cynicism

seroquelA mental health blog I’ve recently started reading, Furious Seasons written by P. Dawdy, has been blogging about Seroquel, a medication that has normally been used for acute mania in bipolar disorder. Now, Seroquel is being pushed for depression in bipolar disorder. In one of his older posts, he wrote: “So my hunch is that there must be money for researchers in going after BP, and Pharma companies must be willing to foot the bill. Yes, I am cynical.”

This has been my thinking for sometime now and I’m glad that someone had the gumption to say so. I’m highly cynical of pharmaceutical companies. Pharmaceutical companies don’t care about whether medications help people as long as they don’t kill anybody, which detracts from their profits in the form of class-action lawsuits. (See the Vioxx case with Merck.)

Dawdy also writes: “We are the only group in the psych business that matters. But our interests are not well served in the current power arrangment, in which we don’t even have much of a share or a voice. That is also bullshit and must change.”

I often feel disconnected from the pharmaceutical industry and the world of psychiatry. I am being told things and diagnosed left and right and I don’t understand much of what I’m being told by anybody. My concern is that clinical trial data is being fudged by doctors who receive funding from pharmaceutical companies but fail to disclose their ties. This area needs government regulation and a higher standard of ethical practice. Perhaps the APA should form a bureaucratic board of ethics specifically to overseen the relation between doctors working with (and often for) pharmaceutical companies.

Mood: 4